How Conflixis Uses AI to Combat Corruption in Hospitals

Conflixis, founded by Aaron Narva, is creating an innovative solution that helps hospitals and healthcare institutions combat corruption risks using artificial intelligence. Inspired by his experience working at major risk management firms like Kroll and FTI Consulting, as well as at Exiger, where he was responsible for compliance monitoring, Narva developed a concept that allows healthcare organizations to identify potential threats related to corruption and conflicts of interest among doctors.

Unlike banks and financial institutions, healthcare organizations face unique risks when doctors may have personal ties with pharmaceutical companies or medical device manufacturers. These connections, if not properly disclosed, can lead to unethical behavior, such as prescribing medications or devices that are not always the best option for patients. Despite existing databases like OpenPaymentsData.com, which track conflict of interest disclosures, the issue remains unresolved as they do not address the core threat to institutions and their patients.

Conflixis uses artificial intelligence to analyze large volumes of data from various sources, including patient treatment outcomes, hospital procurement data, and conflict of interest information. The system enables healthcare institutions to quickly identify the risks that require further investigation. Conflicting moments are sorted and analyzed to provide a clear picture of which interactions between doctors and suppliers could lead to significant legal or medical consequences.

The company not only helps minimize legal risks but also offers solutions for improving financial management. For example, Conflixis can detect when a hospital purchases more expensive equipment based on a doctor's recommendation tied to a supplier. This helps institutions make more informed decisions, significantly reducing costs and increasing patient trust.

Since its founding in 2023, Conflixis has already attracted several clients and successfully completed a $4.2 million seed round. The startup continues to grow and aims to become a leader in ensuring transparency and fighting corruption in healthcare.